Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Breast | 15 | 2024 | 1967 | 1.850 |
Why?
|
Breast Neoplasms | 32 | 2024 | 21019 | 1.450 |
Why?
|
Breast Diseases | 4 | 2021 | 442 | 1.330 |
Why?
|
Body Fluids | 6 | 2013 | 320 | 1.130 |
Why?
|
Labor, Obstetric | 5 | 2016 | 323 | 1.100 |
Why?
|
Testosterone | 4 | 2024 | 2472 | 0.940 |
Why?
|
Premature Birth | 6 | 2020 | 1782 | 0.850 |
Why?
|
Obstetric Labor, Premature | 2 | 2014 | 272 | 0.830 |
Why?
|
Cervix Uteri | 5 | 2013 | 570 | 0.800 |
Why?
|
Vagina | 6 | 2013 | 838 | 0.770 |
Why?
|
Infectious Mononucleosis | 1 | 2022 | 133 | 0.770 |
Why?
|
Nipples | 1 | 2023 | 229 | 0.740 |
Why?
|
Mammary Glands, Human | 1 | 2021 | 203 | 0.670 |
Why?
|
Interleukin 1 Receptor Antagonist Protein | 2 | 2013 | 299 | 0.660 |
Why?
|
Labor Onset | 3 | 2010 | 17 | 0.520 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2022 | 612 | 0.510 |
Why?
|
Abortion, Threatened | 1 | 2014 | 4 | 0.480 |
Why?
|
Retinal Dehydrogenase | 2 | 2024 | 78 | 0.470 |
Why?
|
Mammography | 2 | 2024 | 2430 | 0.460 |
Why?
|
Term Birth | 5 | 2014 | 138 | 0.440 |
Why?
|
Interleukin-1alpha | 1 | 2013 | 86 | 0.420 |
Why?
|
Androgens | 1 | 2020 | 1286 | 0.420 |
Why?
|
Blood Cells | 1 | 2014 | 305 | 0.400 |
Why?
|
Tissue Inhibitor of Metalloproteinase-2 | 1 | 2011 | 72 | 0.390 |
Why?
|
Matrix Metalloproteinase 7 | 1 | 2011 | 60 | 0.380 |
Why?
|
Fetal Membranes, Premature Rupture | 2 | 2013 | 137 | 0.380 |
Why?
|
Serum Albumin | 1 | 2014 | 672 | 0.380 |
Why?
|
Cystatin A | 1 | 2010 | 6 | 0.380 |
Why?
|
Tissue Inhibitor of Metalloproteinase-1 | 1 | 2011 | 151 | 0.380 |
Why?
|
Cervix Mucus | 1 | 2010 | 17 | 0.370 |
Why?
|
Cysteine Proteases | 1 | 2010 | 18 | 0.370 |
Why?
|
Body Mass Index | 5 | 2024 | 12953 | 0.370 |
Why?
|
Receptors, Neurokinin-1 | 1 | 2011 | 134 | 0.360 |
Why?
|
Postmenopause | 2 | 2019 | 2513 | 0.350 |
Why?
|
Diterpenes | 1 | 2011 | 171 | 0.350 |
Why?
|
Gene Expression | 4 | 2020 | 7581 | 0.350 |
Why?
|
Capsaicin | 1 | 2011 | 231 | 0.340 |
Why?
|
Cathepsins | 1 | 2010 | 241 | 0.340 |
Why?
|
Substance P | 1 | 2011 | 335 | 0.340 |
Why?
|
Menarche | 2 | 2024 | 532 | 0.340 |
Why?
|
TRPV Cation Channels | 1 | 2011 | 244 | 0.320 |
Why?
|
Health Surveys | 1 | 2018 | 4061 | 0.310 |
Why?
|
Pregnancy | 15 | 2020 | 29890 | 0.300 |
Why?
|
Female | 54 | 2024 | 392705 | 0.300 |
Why?
|
Nurses | 3 | 2022 | 2478 | 0.290 |
Why?
|
Interleukin-1beta | 1 | 2013 | 999 | 0.290 |
Why?
|
Receptors, Estrogen | 6 | 2022 | 2209 | 0.270 |
Why?
|
Adult | 32 | 2024 | 221210 | 0.260 |
Why?
|
Proteomics | 4 | 2024 | 3848 | 0.250 |
Why?
|
Epidemiology | 2 | 2019 | 279 | 0.250 |
Why?
|
Vaginal Smears | 1 | 2008 | 499 | 0.250 |
Why?
|
Databases, Genetic | 4 | 2020 | 1742 | 0.240 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2016 | 3612 | 0.240 |
Why?
|
Pathology, Molecular | 2 | 2019 | 328 | 0.240 |
Why?
|
Urinary Bladder | 1 | 2011 | 1152 | 0.240 |
Why?
|
Carcinoma, Renal Cell | 1 | 2019 | 3165 | 0.230 |
Why?
|
Gene Expression Profiling | 5 | 2024 | 9420 | 0.220 |
Why?
|
Sex Reassignment Procedures | 1 | 2024 | 70 | 0.220 |
Why?
|
Keratin-7 | 1 | 2023 | 55 | 0.210 |
Why?
|
Humans | 56 | 2024 | 761596 | 0.210 |
Why?
|
Kidney Neoplasms | 1 | 2019 | 4251 | 0.210 |
Why?
|
Receptors, Androgen | 2 | 2019 | 1079 | 0.210 |
Why?
|
Spinal Cord | 1 | 2011 | 1819 | 0.210 |
Why?
|
Parity | 2 | 2021 | 927 | 0.210 |
Why?
|
Antioxidants | 1 | 2010 | 1668 | 0.200 |
Why?
|
Trans-Activators | 3 | 2020 | 2856 | 0.200 |
Why?
|
Middle Aged | 23 | 2024 | 220921 | 0.200 |
Why?
|
Analysis of Variance | 3 | 2021 | 6228 | 0.190 |
Why?
|
Delivery, Obstetric | 1 | 2008 | 941 | 0.180 |
Why?
|
Risk Factors | 15 | 2024 | 74213 | 0.180 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2014 | 3810 | 0.180 |
Why?
|
Gestational Age | 4 | 2020 | 3577 | 0.180 |
Why?
|
Ki-67 Antigen | 1 | 2023 | 629 | 0.180 |
Why?
|
Carcinogens, Environmental | 1 | 2020 | 72 | 0.180 |
Why?
|
Reproductive History | 1 | 2021 | 211 | 0.170 |
Why?
|
Hyperplasia | 1 | 2023 | 1152 | 0.170 |
Why?
|
Neck | 1 | 2024 | 734 | 0.160 |
Why?
|
Radon | 1 | 2020 | 87 | 0.160 |
Why?
|
Erythrocyte Membrane | 1 | 2020 | 439 | 0.160 |
Why?
|
Elasticity | 1 | 2021 | 655 | 0.160 |
Why?
|
Image Processing, Computer-Assisted | 3 | 2020 | 9001 | 0.150 |
Why?
|
Alcohol Drinking | 3 | 2023 | 4028 | 0.150 |
Why?
|
Body Size | 1 | 2021 | 463 | 0.150 |
Why?
|
Pregnancy Outcome | 1 | 2008 | 2922 | 0.140 |
Why?
|
Sex Reassignment Surgery | 1 | 2020 | 164 | 0.140 |
Why?
|
Mammary Neoplasms, Animal | 1 | 2018 | 125 | 0.140 |
Why?
|
RNA, Messenger | 3 | 2020 | 12794 | 0.140 |
Why?
|
Automation | 1 | 2019 | 586 | 0.140 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2022 | 1092 | 0.140 |
Why?
|
Gene Fusion | 1 | 2019 | 356 | 0.140 |
Why?
|
Predictive Value of Tests | 5 | 2021 | 15266 | 0.140 |
Why?
|
Mammary Glands, Animal | 1 | 2018 | 273 | 0.140 |
Why?
|
Gene Expression Regulation | 1 | 2014 | 11904 | 0.130 |
Why?
|
Risk Assessment | 5 | 2021 | 23996 | 0.130 |
Why?
|
Herpesvirus 4, Human | 1 | 2022 | 1078 | 0.130 |
Why?
|
MicroRNAs | 2 | 2024 | 3816 | 0.130 |
Why?
|
Multifactorial Inheritance | 1 | 2024 | 1387 | 0.130 |
Why?
|
Lymphatic Metastasis | 1 | 2024 | 2915 | 0.130 |
Why?
|
Neoplasms, Hormone-Dependent | 1 | 2018 | 410 | 0.130 |
Why?
|
Cystadenocarcinoma, Serous | 1 | 2019 | 478 | 0.120 |
Why?
|
Proteins | 1 | 2010 | 6032 | 0.120 |
Why?
|
Western Australia | 1 | 2014 | 41 | 0.120 |
Why?
|
Genomics | 3 | 2022 | 5821 | 0.120 |
Why?
|
Kaplan-Meier Estimate | 3 | 2019 | 6484 | 0.120 |
Why?
|
Case-Control Studies | 7 | 2021 | 22176 | 0.120 |
Why?
|
Body Height | 1 | 2020 | 1570 | 0.120 |
Why?
|
Genes, Reporter | 1 | 2018 | 1529 | 0.120 |
Why?
|
Prognosis | 8 | 2024 | 29629 | 0.110 |
Why?
|
Adiposity | 2 | 2021 | 1879 | 0.110 |
Why?
|
Aldehyde Dehydrogenase | 2 | 2024 | 146 | 0.110 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 1 | 2021 | 926 | 0.110 |
Why?
|
Neoplasm Invasiveness | 2 | 2024 | 3597 | 0.110 |
Why?
|
Reproducibility of Results | 4 | 2021 | 20100 | 0.110 |
Why?
|
Menopause | 1 | 2021 | 1646 | 0.100 |
Why?
|
Cell Cycle Proteins | 1 | 2024 | 3449 | 0.100 |
Why?
|
Lymph Nodes | 1 | 2024 | 3465 | 0.100 |
Why?
|
Fatty Acids | 1 | 2020 | 1808 | 0.100 |
Why?
|
Area Under Curve | 1 | 2016 | 1638 | 0.100 |
Why?
|
Disease Susceptibility | 1 | 2018 | 1787 | 0.100 |
Why?
|
Inflammation Mediators | 1 | 2020 | 1886 | 0.100 |
Why?
|
Estradiol | 1 | 2018 | 1937 | 0.090 |
Why?
|
Unsafe Sex | 1 | 2013 | 238 | 0.090 |
Why?
|
Demography | 1 | 2016 | 1648 | 0.090 |
Why?
|
DNA Copy Number Variations | 1 | 2020 | 2020 | 0.090 |
Why?
|
Time Factors | 5 | 2014 | 39969 | 0.090 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2019 | 1520 | 0.090 |
Why?
|
Thyroid Neoplasms | 1 | 2024 | 2332 | 0.090 |
Why?
|
Proteome | 2 | 2013 | 1862 | 0.090 |
Why?
|
Biopsy | 4 | 2024 | 6766 | 0.090 |
Why?
|
Fibronectins | 1 | 2014 | 723 | 0.090 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2020 | 3779 | 0.090 |
Why?
|
Computational Biology | 2 | 2020 | 3517 | 0.090 |
Why?
|
Signal Transduction | 1 | 2013 | 23447 | 0.090 |
Why?
|
Amniotic Fluid | 1 | 2011 | 378 | 0.080 |
Why?
|
Thioredoxins | 1 | 2010 | 202 | 0.080 |
Why?
|
Sacrum | 1 | 2011 | 276 | 0.080 |
Why?
|
Risk | 1 | 2021 | 9610 | 0.080 |
Why?
|
Statistics, Nonparametric | 1 | 2014 | 2850 | 0.080 |
Why?
|
High-Throughput Screening Assays | 1 | 2014 | 934 | 0.080 |
Why?
|
Phthalazines | 2 | 2022 | 383 | 0.080 |
Why?
|
Environmental Exposure | 2 | 2020 | 4485 | 0.080 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2024 | 9280 | 0.080 |
Why?
|
Head and Neck Neoplasms | 1 | 2022 | 2894 | 0.080 |
Why?
|
Infant, Small for Gestational Age | 1 | 2011 | 461 | 0.070 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2021 | 3359 | 0.070 |
Why?
|
Superoxide Dismutase | 1 | 2010 | 594 | 0.070 |
Why?
|
Anthropometry | 2 | 2024 | 1349 | 0.070 |
Why?
|
Cohort Studies | 4 | 2024 | 41495 | 0.070 |
Why?
|
Mass Spectrometry | 1 | 2014 | 2192 | 0.070 |
Why?
|
Logistic Models | 1 | 2022 | 13255 | 0.070 |
Why?
|
Protease Inhibitors | 1 | 2010 | 754 | 0.070 |
Why?
|
Rats, Wistar | 1 | 2011 | 1848 | 0.070 |
Why?
|
Labor, Induced | 1 | 2008 | 152 | 0.070 |
Why?
|
Aged | 6 | 2024 | 169310 | 0.070 |
Why?
|
Mitosis | 2 | 2024 | 1188 | 0.070 |
Why?
|
Vitamin D | 1 | 2020 | 3303 | 0.070 |
Why?
|
Air Pollution | 1 | 2020 | 2359 | 0.070 |
Why?
|
Models, Genetic | 1 | 2016 | 3442 | 0.070 |
Why?
|
Air Pollutants | 1 | 2020 | 2896 | 0.060 |
Why?
|
Nerve Tissue Proteins | 1 | 2018 | 4415 | 0.060 |
Why?
|
Maternal Age | 1 | 2008 | 809 | 0.060 |
Why?
|
Receptors, Progesterone | 2 | 2020 | 1129 | 0.060 |
Why?
|
Oxidation-Reduction | 1 | 2010 | 2231 | 0.060 |
Why?
|
Male | 7 | 2024 | 360846 | 0.060 |
Why?
|
Retrospective Studies | 5 | 2024 | 80647 | 0.060 |
Why?
|
Infant, Newborn | 4 | 2020 | 26202 | 0.050 |
Why?
|
Phenotype | 2 | 2022 | 16592 | 0.050 |
Why?
|
Giant Cells | 1 | 2023 | 188 | 0.050 |
Why?
|
Probability | 1 | 2008 | 2477 | 0.050 |
Why?
|
Multivariate Analysis | 1 | 2016 | 12059 | 0.050 |
Why?
|
Ovarian Neoplasms | 1 | 2019 | 4878 | 0.050 |
Why?
|
Genetic Predisposition to Disease | 1 | 2024 | 17904 | 0.050 |
Why?
|
Birth Weight | 1 | 2011 | 2103 | 0.050 |
Why?
|
Genome-Wide Association Study | 1 | 2022 | 12690 | 0.050 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2022 | 2865 | 0.050 |
Why?
|
Protein Stability | 1 | 2024 | 578 | 0.050 |
Why?
|
Age Factors | 3 | 2024 | 18399 | 0.050 |
Why?
|
Nucleic Acid Amplification Techniques | 1 | 2024 | 330 | 0.050 |
Why?
|
Longitudinal Studies | 2 | 2020 | 14608 | 0.050 |
Why?
|
Mammary Neoplasms, Experimental | 1 | 2024 | 507 | 0.050 |
Why?
|
Adenosine Diphosphate | 1 | 2022 | 422 | 0.050 |
Why?
|
Adolescent | 4 | 2022 | 88326 | 0.050 |
Why?
|
Lumbar Vertebrae | 1 | 2011 | 1879 | 0.050 |
Why?
|
Membrane Proteins | 1 | 2018 | 7859 | 0.050 |
Why?
|
Stem Cells | 2 | 2024 | 3524 | 0.050 |
Why?
|
Tumor Microenvironment | 2 | 2024 | 3878 | 0.040 |
Why?
|
Mastectomy | 2 | 2019 | 1822 | 0.040 |
Why?
|
Niacinamide | 1 | 2022 | 413 | 0.040 |
Why?
|
Gene Expression Regulation, Neoplastic | 3 | 2024 | 8554 | 0.040 |
Why?
|
Alberta | 1 | 2020 | 68 | 0.040 |
Why?
|
Regression Analysis | 1 | 2010 | 6345 | 0.040 |
Why?
|
Obesity | 2 | 2021 | 12947 | 0.040 |
Why?
|
Young Adult | 3 | 2022 | 59260 | 0.040 |
Why?
|
Tissue Array Analysis | 1 | 2021 | 550 | 0.040 |
Why?
|
Cesarean Section | 1 | 2008 | 1398 | 0.040 |
Why?
|
Oxidative Stress | 1 | 2010 | 3113 | 0.040 |
Why?
|
Child | 3 | 2022 | 80158 | 0.040 |
Why?
|
Algorithms | 1 | 2019 | 14033 | 0.040 |
Why?
|
Keratin-8 | 1 | 2018 | 11 | 0.040 |
Why?
|
Mutation | 2 | 2022 | 30053 | 0.040 |
Why?
|
Premenopause | 1 | 2023 | 1039 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2011 | 10766 | 0.040 |
Why?
|
Estrogen Antagonists | 1 | 2019 | 150 | 0.040 |
Why?
|
Keratin-14 | 1 | 2018 | 56 | 0.040 |
Why?
|
NAD | 1 | 2022 | 614 | 0.040 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2022 | 899 | 0.040 |
Why?
|
Clinical Trials, Phase I as Topic | 1 | 2019 | 326 | 0.040 |
Why?
|
Germ Cells | 1 | 2022 | 634 | 0.040 |
Why?
|
Pregnancy Trimester, Third | 1 | 2020 | 583 | 0.040 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2022 | 621 | 0.040 |
Why?
|
PTEN Phosphohydrolase | 1 | 2022 | 1115 | 0.030 |
Why?
|
Epithelium | 1 | 2021 | 1603 | 0.030 |
Why?
|
Morpholines | 1 | 2019 | 581 | 0.030 |
Why?
|
Pathology | 1 | 2019 | 270 | 0.030 |
Why?
|
Cytokines | 1 | 2011 | 7396 | 0.030 |
Why?
|
Aminopyridines | 1 | 2019 | 573 | 0.030 |
Why?
|
Cell Cycle | 1 | 2024 | 2932 | 0.030 |
Why?
|
Stromal Cells | 1 | 2021 | 1330 | 0.030 |
Why?
|
Aromatase Inhibitors | 1 | 2019 | 513 | 0.030 |
Why?
|
Rats | 1 | 2011 | 23741 | 0.030 |
Why?
|
Reactive Oxygen Species | 1 | 2022 | 2139 | 0.030 |
Why?
|
Microarray Analysis | 1 | 2017 | 750 | 0.030 |
Why?
|
Tamoxifen | 1 | 2019 | 965 | 0.030 |
Why?
|
Cell Line, Tumor | 2 | 2022 | 16990 | 0.030 |
Why?
|
Estrogen Receptor alpha | 1 | 2017 | 583 | 0.030 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2023 | 2917 | 0.030 |
Why?
|
Sensitivity and Specificity | 1 | 2008 | 14665 | 0.030 |
Why?
|
Phosphorylation | 1 | 2024 | 8321 | 0.030 |
Why?
|
Green Fluorescent Proteins | 1 | 2018 | 2065 | 0.030 |
Why?
|
Validation Studies as Topic | 1 | 2013 | 162 | 0.030 |
Why?
|
Forkhead Transcription Factors | 1 | 2019 | 1616 | 0.030 |
Why?
|
Chromatin | 1 | 2023 | 2961 | 0.020 |
Why?
|
Neoplasms | 2 | 2019 | 22173 | 0.020 |
Why?
|
Prospective Studies | 3 | 2020 | 54423 | 0.020 |
Why?
|
Cell Division | 1 | 2018 | 4465 | 0.020 |
Why?
|
Animals | 4 | 2024 | 168475 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2019 | 3514 | 0.020 |
Why?
|
Cross-Sectional Studies | 1 | 2011 | 26129 | 0.020 |
Why?
|
Receptor, erbB-2 | 1 | 2020 | 2557 | 0.020 |
Why?
|
Adipose Tissue | 1 | 2021 | 3313 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2018 | 6214 | 0.020 |
Why?
|
Piperazines | 1 | 2019 | 2523 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2022 | 4580 | 0.020 |
Why?
|
Repressor Proteins | 1 | 2019 | 2986 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2019 | 6815 | 0.020 |
Why?
|
Particulate Matter | 1 | 2020 | 2605 | 0.020 |
Why?
|
Specimen Handling | 1 | 2013 | 702 | 0.020 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 1 | 2008 | 283 | 0.020 |
Why?
|
Disease Management | 1 | 2018 | 2508 | 0.020 |
Why?
|
Macrophages | 1 | 2022 | 5767 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2018 | 4915 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2018 | 5790 | 0.020 |
Why?
|
Pregnancy Trimester, First | 1 | 2011 | 907 | 0.020 |
Why?
|
Protein Array Analysis | 1 | 2008 | 400 | 0.020 |
Why?
|
Epithelial Cells | 1 | 2018 | 3677 | 0.020 |
Why?
|
Cell Movement | 1 | 2018 | 5205 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2018 | 9542 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2019 | 12463 | 0.010 |
Why?
|
Diet | 1 | 2022 | 8075 | 0.010 |
Why?
|
Mice | 2 | 2024 | 81539 | 0.010 |
Why?
|
Boston | 1 | 2017 | 9327 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2019 | 10451 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2020 | 39106 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2019 | 11742 | 0.010 |
Why?
|
Child, Preschool | 1 | 2020 | 42232 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2008 | 13446 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2008 | 17635 | 0.010 |
Why?
|